Ardent Health, Inc. (ARDT)
NYSE: ARDT · Real-Time Price · USD
17.65
+0.35 (2.02%)
Nov 9, 2026, 9:50 AM EST - Market open

Ardent Health Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2,4871,2642,438---
Market Cap Growth
18.49%-48.14%----
Enterprise Value
3,9863,3284,499---
Last Close Price
17.308.8317.08---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
17.149.3111.59---
Forward PE
13.846.838.79---
PS Ratio
0.380.200.41---
PB Ratio
1.750.751.60---
P/TBV Ratio
5.453.9612.05---
P/FCF Ratio
8.644.8919.12---
P/OCF Ratio
5.062.697.74---
PEG Ratio
2.573.840.12---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
0.610.530.75---
EV/EBITDA Ratio
7.826.918.15---
EV/EBIT Ratio
11.6910.2211.09---
EV/FCF Ratio
13.9512.8735.28---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
1.271.381.502.212.28-
Debt / EBITDA Ratio
2.953.132.843.994.26-
Debt / FCF Ratio
8.028.9917.9028.43--
Net Debt / Equity Ratio
0.840.961.131.801.83-
Net Debt / EBITDA Ratio
2.983.353.115.455.67-
Net Debt / FCF Ratio
5.316.2413.4523.05-10.12-
Asset Turnover
1.231.231.231.18--
Inventory Turnover
22.7622.7522.9822.42--
Quick Ratio
1.401.421.441.301.38-
Current Ratio
2.131.971.941.631.74-
Return on Equity (ROE)
13.52%14.35%23.01%12.10%--
Return on Assets (ROA)
4.01%3.97%5.24%2.93%--
Return on Invested Capital (ROIC)
8.13%8.01%10.70%6.13%5.75%-
Return on Capital Employed (ROCE)
7.80%7.70%10.10%5.80%5.50%-

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
5.83%10.74%8.63%---
FCF Yield
11.58%20.45%5.23%---
Payout Ratio
----92.54%40.27%
Buyback Yield / Dilution
-0.65%-6.56%-5.26%---
SEC Filings: 10-K · 10-Q